As seen in studies on ischemic stroke, the short half-life of tPA also opens up possibilities for higher dose tPA boluses given over a few minutes while a DCD liver is on EVLP without significantly risking intrahepatic bleeding (35). The gene discussed is PLAT; the disease is ischemic stroke.